1. KRAS-dependent sorting of miRNA to exosomes
   Diana J Cha et al, 2015 CrossRef
2. miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy
   Junfei Guo et al, 2015, J. Biol. Chem. CrossRef
3. miR-150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma
   Xiangyong Li et al, 2017 CrossRef
4. miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7
   SHAO-MEI ZHOU et al, 2016 CrossRef
5. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy
   Chu Qin et al, 2015, Tumor Biol. CrossRef
6. The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges
   Eun-Jin Yun et al, 2016, Asian Journal of Urology CrossRef
7. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer
   Shuai Huang et al, 2017, J Exp Clin Cancer Res CrossRef
8. MicroRNAs targeting prostate cancer stem cells
   Yu-Xiang Fang et al, 2015, Exp Biol Med (Maywood) CrossRef
9. MicroRNAs and Bone Metastasis: A New Challenge
   Martine Croset et al, 2014, Molecules CrossRef
10. MiR-184 expression is regulated by AMPK in pancreatic islets
    Aida Martinez-Sanchez et al, 2018, The FASEB Journal CrossRef
11. null
    Hideki Enokida, 2018 CrossRef
12. Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy
    Alicia C. McDonald et al, 2019, The Prostate CrossRef
13. Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors
    K A Garbett et al, 2015, Transl Psychiatry CrossRef
14. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening
    Hui Wang et al, 2014, Med Oncol CrossRef
15. miR-100 suppresses mTOR signaling in hypoxia-induced pulmonary hypertension in rats
    Ai-ping Wang et al, 2015, European Journal of Pharmacology CrossRef
16. Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis
    Peiyao Li et al, 2015, BMC Cancer CrossRef
17. Molecular mechanisms of microRNAs in regulating epithelial–mesenchymal transitions in human cancers
    Jinlong Tang et al, 2016, Cancer Letters CrossRef
18. MiRNA 34a: a therapeutic target for castration-resistant prostate cancer.
    Marine J Chalanqui et al, 0 CrossRef
19. MicroRNA Exert Macro Effects on Cancer Bone Metastasis
    Scott R. Baier et al, 2016, Curr Osteoporos Rep CrossRef
20. Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy
    Bijaya Malla et al, 2017, International Journal of Radiation Oncology*Biology*Physics CrossRef
21. miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.
    Noushin Nabavi et al, 2017, Sci Rep CrossRef
22. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Dong Ren et al, 2017, Mol Cancer CrossRef
23. Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer
    Eoghan J. Mulholland et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
24. Role of miRNAs in prostate cancer: Do we really know everything?
    Giovanni Cochetti et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef
25. hsa-miR-100-5p, an overexpressed miRNA in human ovarian endometriotic stromal cells, promotes invasion through attenuation of SMARCD1 expression
    Kanetoshi Takebayashi et al, 2020, Reprod Biol Endocrinol CrossRef
26. MicroRNAs and epithelial-mesenchymal transition in prostate cancer
    Kirandeep Sekhon et al, 2016, Oncotarget CrossRef
27. MiR-195 enhances cardiomyogenic differentiation of the proepicardium/septum transversum by Smurf1 and Foxp1 modulation
    Angel Dueñas et al, 2020, Sci Rep CrossRef
28. From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies
    Vasiliki I. Pantazopoulou et al, 2020, IJMS CrossRef
29. LncRNA TUG1 Promotes Hepatocellular Carcinoma Migration and Invasion Via Targeting miR-137/AKT2 Axis
    Wei Li et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
30. Role of microRNA‑150‑5p/SRCIN1 axis in the progression of breast cancer
    Qingfu Lu et al, 2019, Exp Ther Med CrossRef
31. Prognostic value and prospective molecular mechanism of miR‑100‑5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples
    Qing‑Lin He et al, 2019, Oncol Lett CrossRef
32. Biological significance of piRNA in liver cancer: a review
    Jiamin Xu et al, 2020, Biomarkers CrossRef
33. MicroRNA-99 family in cancer and immunity.
    Joseph Eniafe et al, 2021, Wiley Interdiscip Rev RNA CrossRef
34. miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells
    Yun Ye et al, 2020, Front. Oncol. CrossRef
35. Loss of miR-100 and miR-125b results in cancer stem cell properties through IGF2 upregulation in hepatocellular carcinoma
    Hyang Sook Seol et al, 2020, Sci Rep CrossRef
36. Argonaute 3 (AGO3) promotes malignancy potential of cervical cancer via regulation of Wnt/β-catenin signaling pathway
    Liuliu Pan et al, 2021, Reproductive Biology CrossRef
37. miR-100 alleviates the inflammatory damage and apoptosis of H2O2-induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting MMP9
    Chen Wang et al, 2021, Vascular CrossRef
38. miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools
    Leonardo J. Galvão-Lima et al, 2021, BioMed Eng OnLine CrossRef
39. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
    Maria Dobre et al, 2021, Cells CrossRef
40. miRNAs and androgen deprivation therapy for prostate cancer
    Konoshenko Maria Yu et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
41. Decreased miR-218–5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer
    Peng Peng et al, 2019, Oncol Res Treat CrossRef
42. The Activation of Mesenchymal Stem Cells by Glioblastoma Microvesicles Alters Their Exosomal Secretion of miR-100-5p, miR-9-5p and let-7d-5p
    Delphine Garnier et al, 2022, Biomedicines CrossRef
43. Fusing Multiple Biological Networks to Effectively Predict miRNA-disease Associations
    Qingqi Zhu et al, 2021, CBIO CrossRef
44. A cellular regulator of the niche: telocyte
    Sena Babadag et al, 2022, Tissue Barriers CrossRef
45. State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer
    Saravanan Ramesh et al, 2023, Front. Oncol. CrossRef
46. Downregulated miR-100 Result in High Expression Levels of Chemokine (CXC Motif) Receptor 7 That Predict Recurrence of Lung Cancer
    Liu-Jie Gao et al, 2023, j biomater tissue eng CrossRef
47. Screening and validation of novel serum panel of microRNA in stratification of prostate cancer.
    Anveshika Manoj et al, 2023, Prostate International CrossRef
48. The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach
    Anne Natalie Prigol et al, 2023, Cancers CrossRef
49. null
    Sana Hachem et al, 2024 CrossRef